Skip to main content
SpringerLink
Log in

Preparation and Evaluation of Probucol-Phospholipid Complex with Enhanced Bioavailability and No Food Effect

  • Research Article
  • Theme: Lipid-Based Drug Delivery Strategies for Oral Drug Delivery
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

To enhance the oral bioavailability and eliminate the food effect of probucol. Probucol-phospholipid complex was prepared using solvent-evaporation method in this research. Several methods were used to validate the formation of complexes, such as FT-IR, SEM, DSC and PXRD, and the solubility of PRO and PRO-PLC was detected by HPLC. Pharmacokinetic testing was conducted in the fasted and fed state. FTIR, SEM, DSC and PXRD validated the existence of PRO-PLC. The solubility of PRO in complexes was 15.05 μg/mL, which was 215-fold of the PRO-API. The dissolution rate was increased by preparing PRO-PLC. Compared with commercial tablets, the PRO-PLC complexes exhibited higher peak plasma concentration (1.69 ± 0.44 μg/mL), increased AUC0–24 h (6.8 ± 1.3 μg/mL h), which mean the bioavailability of PRO was increased. In addition, the absorption of PRO was not interfered with food. In conclusion, an improved solubility and bioavailability was achieved with the preparation of PRO-PLC. Additionally, the dissolution behaviour was good and the food effect was eliminated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Kubo Y, Terashima Y, Yagi N, Nochi H, Tamoto K, Sekikawa H. Enhanced bioavailability of probucol following the administration of solid dispersion systems of probucol-polyvinylpyrrolidone in rabbits. Biol Pharm Bull. 2009;32:1880–4.

    Article  CAS  Google Scholar 

  2. Shudo J, Pongpeerapat A, Wanawongthai C, Moribe K, Yamamoto K. In vivo assessment of oral administration of probucol nanoparticles in rats. Biol Pharm Bull. 2008;31:321–5.

    Article  CAS  Google Scholar 

  3. Russell JC, Graham SE, Amy RM, Dolphin PJ. Cardioprotective effect of probucol in the atherosclerosis-prone JCR LA-cp rat. Eur J Pharmacol. 1998;350:203–10.

    Article  CAS  Google Scholar 

  4. Zaitseva TM, Lupanov VP, Lyakishev AA, Titov VN, Polevaya TY. Pharmacokinetics of probucol dosage forms in clinical tests. Pharma Chem. 1995;29:21–3.

    CAS  Google Scholar 

  5. Heeg JF, Hiser MF, Satonin DK, Rose JQ. Pharmacokinetics of probucol in male rats. J Pharm Sci. 1984;73:1758–63.

    Article  CAS  Google Scholar 

  6. Io T, Fukami T, Yamamoto K, Suzuki T, Xu JD, Tomono K. Homogeneous nanoparticles to enhance the efficiency of ahydrophobic drug anti-hyperlipidemic probucol characterized by solid-state NMR. Mol Pharm. 2009;7:1–12.

    Google Scholar 

  7. Nielsen FS, Petersen KB, Mullertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm. 2008;69:553–62.

    Article  CAS  Google Scholar 

  8. Xianyi S, Juan W, Yanzuo C, Xiaoling F. Self-microemulsifying drug delivery system for improved oral bioavailability of probucol: preparation and evaluation. Int J Nanomedicine. 2012;7:705–12.

    Article  Google Scholar 

  9. Miao Y, Chen G, Ren L. Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect. J Pharm Pharmacol. 2016;68(2):185–94.

    Article  CAS  Google Scholar 

  10. Singh C. Novel rifampicinphospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation. Int J Pharm. 2014;460:220–7.

    Article  CAS  Google Scholar 

  11. Gupta NK. Bioavailability enhancement of curcumin by complexation with phosphatidylcholine. J Pharm Sci. 2011;100:1987–95.

    Article  CAS  Google Scholar 

  12. Yu JN. Enhancement of oral bioavailability of the poorly water soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin. 2010;31:759–64.

    Article  CAS  Google Scholar 

  13. Hequn M. Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia. 2014;93:54–61.

    Article  Google Scholar 

  14. Khan J, Alexander A, Ajazuddin Saraf S, Saraf S. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release. 2013;168:50–60.

    Article  CAS  Google Scholar 

  15. Afanaseva YG, Fakhretdinova ER, Spirikhin LV, Nasibullin RS. Mechanism of interaction of certain flavonoids with phosphatidylcholine of cellular membranes. Pharm Chem J. 2007;41:354–6.

    Article  CAS  Google Scholar 

  16. Mezghrani O, Ke X, Bourkaib N, Xu BH. Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbin. Pharmazie. 2011;66:754–60.

    CAS  PubMed  Google Scholar 

  17. National Pharmacopoeia Commission. “Chinese Pharmacopoeia 2015” version II [S]. Beijing: China Medical Sci Technol Press; 2015. Appendix XI XC Guidelines for Stability Testing of APIs and Pharmaceutical Preparations.

    Google Scholar 

  18. Kim Y. Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl ether. J Pharm Sci. 1998;87:1560–7.

    Article  CAS  Google Scholar 

  19. Bei G. Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods. Int J Pharm. 2014;474:50–6.

    Article  Google Scholar 

  20. Jena SK. Development of tamoxifen-phospholipid complex: novel approach for improving solubility and bioavailability. Int J Pharm. 2014;473:1–9.

    Article  CAS  Google Scholar 

  21. Semalty A. Development and physicochemical evaluation of pharmacosomes of diclofenac. Acta Pharma. 2009;59:335–44.

    Article  CAS  Google Scholar 

  22. Yanyu X. The preparation of silybin phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm. 2006;307:7–82.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, Nanjing Tech University, 5th Mofan Road, Nanjing, 21009, China

    Yiwen Qian, Guoguang Chen, Jin Wang & Lili Ren

Authors
  1. Yiwen Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guoguang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lili Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lili Ren.

Additional information

Guest Editor: Sanyog Jain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qian, Y., Chen, G., Wang, J. et al. Preparation and Evaluation of Probucol-Phospholipid Complex with Enhanced Bioavailability and No Food Effect. AAPS PharmSciTech 19, 3599–3608 (2018). https://doi.org/10.1208/s12249-018-1157-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-018-1157-2

KEY WORDS

Search

Navigation